MENU
+Compare
AMRN
Stock ticker: NASDAQ
AS OF
Jan 30 closing price
Price
$0.58
Change
+$0.02 (+3.57%)
Capitalization
357.53M

AMRN Amarin Corp Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AMRN with price predictions
Jan 29, 2025

AMRN in upward trend: price rose above 50-day moving average on January 02, 2025

AMRN moved above its 50-day moving average on January 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for AMRN crossed bullishly above the 50-day moving average on January 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRN advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 94 cases where AMRN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMRN moved out of overbought territory on January 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where AMRN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMRN broke above its upper Bollinger Band on January 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.641) is normal, around the industry mean (5.632). P/E Ratio (67.114) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.000) settles around the average of (0.164) among similar stocks. P/S Ratio (1.172) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

View a ticker or compare two or three
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AMRN is expected to report earnings to rise 6.60% to -5 cents per share on February 26

Amarin Corp AMRN Stock Earnings Reports
Q4'24
Est.
$-0.05
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.02
The last earnings report on October 30 showed earnings per share of -5 cents, beating the estimate of -5 cents. With 789.15K shares outstanding, the current market capitalization sits at 357.53M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVVX57.01N/A
N/A
Touchstone Growth Opportunities Instl
HAGAX75.47N/A
N/A
Carillon Eagle Mid Cap Growth A
MNBIX19.81N/A
N/A
Manning & Napier Pro-Blend Extnd Term I
BDFIX34.98N/A
N/A
Baron Discovery Institutional
JMCGX23.89N/A
N/A
Jacob Discovery Fd Inv

AMRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+2.94%
KZR - AMRN
56%
Loosely correlated
+0.78%
CNTB - AMRN
55%
Loosely correlated
N/A
HRTX - AMRN
44%
Loosely correlated
+3.59%
MGNX - AMRN
44%
Loosely correlated
-0.66%
ALXO - AMRN
43%
Loosely correlated
-10.62%
More